|
Market Closed -
Euronext Paris
20:55:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1610 EUR | -0.98% |
|
-12.21% | -31.20% |
| 10-19 | Poxel increases revenue by half in 3Q |  |
| 09-04 | Laure-Hélène Mercier takes over as chair of Poxel's board | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| POXEL | Bio Therapeutic Drugs | -0.98% | -12.21% | -31.20% | -52.86% | -97.26% | 9.73M |  | |  |
- Stock Market
- Stocks
- POXEL Stock
- Charts Poxel
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
